Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 654 (LINC00654) is a long non-coding RNA (lncRNA) gene located on chromosome 20p12.3, also known as LINC01729 or ENSG00000205181[1][3]. As a member of the lncRNA class, LINC00654 does not code for a protein but is involved in the regulation of gene expression networks and interacts with various mRNA targets. LINC00654 functions as a “hub lncRNA” and is implicated in the regulation of cell signaling pathways including GTPase signaling, Notch and Hedgehog signaling, cell cycle, immune modulation, and tissue homeostasis[2][3][6][7]. It is upregulated in several cancers, such as breast, colorectal, ovarian cancer, and diffuse large B-cell lymphoma, where it frequently acts as a risk or prognostic factor[2][7]. Outside cancer, LINC00654 is associated with the regulation of extracellular matrix and chondrocyte homeostasis (in osteoarthritis) and is differentially expressed during spermatogenesis[7]. LINC00654 is not currently a direct therapeutic target (no drugs known to act on it directly), but its roles as a biomarker and regulator of disease-relevant pathways make it of growing biomedical interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 654 (LINC00654).